News
Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.
Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an analysis of LLY stock now.
TikToker Symone Jade noticed a number of surprising side effects after she temporarily stopped taking Mounjaro.
Mounjaro users on Reddit are complaining of developing 'creepy' and 'saggy' skin on their necks after losing weight on GLP-1 ...
Eli Lilly is the safer bet, as it has a deep lineup and pipeline of products, generates significant revenue that has been ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin drug strategy.
Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...
7don MSN
Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results